ÂÜÀòÂÒÂ×

Clara Tourino is a seasoned professional in pharmacology and neuroscience, currently serving as Director at Switch Therapeutics since May 2023. As a Scientist in in vivo pharmacology at Prothena Corporation plc since May 2016, Clara has led the in vivo pharmacology team, overseeing programs from target identification to candidate selection and managing research animal facilities. Prior experience includes a Postdoctoral Research Scholar position at Stanford University School of Medicine, where Clara characterized neuronal circuits using optogenetics, and a Graduate Student role at Universitat Pompeu Fabra, focusing on brain receptor roles in drug effects. Clara's educational background includes a B.S. and Ph.D. in Human Biology and Neuropharmacology from Pompeu Fabra University.